• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

David Tepper made it official today, he wants Saunders head on a pike.

anonymous

Guest
The thing is when Tepper has his trophy he will probably find out that Allergan is in much worse shape than anyone could have imagined. The non GAAP will not pass the sniff test with anyone from the outside.
 








The thing is when Tepper has his trophy he will probably find out that Allergan is in much worse shape than anyone could have imagined. The non GAAP will not pass the sniff test with anyone from the outside.




Have to agree- AGN has financial issues (no earnings) which investors have concerns about. The suppressed stock is a result more of the financial mess than LOE. Need management out so quality people can run this business. At least Tepper can see the inadequacies with Saunders and his hired morons! Change has to happen somewhere. Saunders is banking on AMD, depression and migraine. If any of these fail in safety studies this whole mess comes to a crashing halt!